Title

Lead Optimization of Second-Generation Acridones As Broad-Spectrum Antimalarials

Published In

Journal of Medicinal Chemistry

Document Type

Post-Print

Publication Date

6-11-2020

Abstract

The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an urgent need for novel, affordable, and safe drugs for prevention and treatment of malaria. Previously, we described a novel antimalarial acridone chemotype that is potent against both blood-stage and liver-stage malaria parasites. Here, we describe an optimization process that has produced a second-generation acridone series with significant improvements in efficacy, metabolic stability, pharmacokinetics, and safety profiles. These findings highlight the therapeutic potential of dual-stage targeting acridones as novel drug candidates for further preclinical development.

Description

This is the Author's Accepted Manuscript of an article that was subsequently published in Journal of Medicinal Chemistry, Volume 63, June 2020, published by American Chemical Society. The version of record may be found at https://doi.org/10.1021/acs.jmedchem.0c00539

DOI

10.1021/acs.jmedchem.0c00539

Persistent Identifier

https://archives.pdx.edu/ds/psu/34035

Share

COinS